View Press Releases
-
Full-Scale PROTAC In Vivo Evaluation Services to Facilitate PROTAC Drug R&D
BOC Sciences can take care of the PROTAC in vivo evaluation workload for clients with a transparent project process and comprehensive evaluation reports to facilitate PROTAC discovery and development programs prior to clinical trials.
Nov 6, 2022
-
Synthetic Biology Platform: Meet All Synthetic Biology Demands in One Place
The Synthetic Biology Platform is designed to program comprehensive biosynthesis development in one place.
Nov 6, 2022
-
New tool to identify patients at high risk of Kidney Dysfunction presented at American Society of Nephrology Conference
A new tool has been developed to identify those diabetes patients who are at risk of developing Chronic Kidney Disease. Early diagnosis can lead to earlier treatment and save lives.
Nov 6, 2022
-
CD ComputaBio Introduces Four Docking Software for Drug Development
-
Pronalyse Supports Drug Discovery with the Launch of Biosimilar Analysis Solutions
-
Creative Proteomics Boosts Your Project with Unknown Metabolite Identification Services
-
Creative Proteomics Cytokine Announces the Launch of Chemokine Detection Service
-
Vermont Initiative Gives Clinicians New Tools for Infectious Disease Diagnosis and Response
I wanted to share the Vermont Department of Health and VisualDx just launched the Clinician Support Initiative to help healthcare professionals respond to emergent infectious disease outbreaks, like Monkeypox, Covid, and Polio, by leveraging assistive technology. Given the challenge of identifying and treating rare diseases amid ongoing staffing and burnout issues, Vermont is offering all clinicians in the state free access to VisualDx’s diagnostic support platform. The tool contains clinical information, medical reference images, and real-time reporting, all of which are critical for patient care and public health response.
Nov 2, 2022
-
medmix Drug Delivery (Haselmeier™) and AARDEX® Group Join Forces to Improve Self-Administration of Injectable Drugs in Clinical Trials
medmix Drug Delivery (Haselmeier™) and AARDEX® Group Join Forces to Improve Self-Administration of Injectable Drugs in Clinical Trials. Liege, Belgium - November 3, 2022: medmix Drug Delivery (Haselmeier) and AARDEX Group announced today a collaboration, combining Haselmeier´s D-Flex™ Logbook with AARDEX Group’s Medication Adherence software and hardware ecosystem.
Nov 2, 2022
-
Jumo Health Honored in Inc.’s Inaugural Power Partner Awards
Jumo Health, a global provider of age appropriate, culturally sensitive medical education resources, today announced it has been recognized by Inc. Magazine in its inaugural Power Partner Awards.
Nov 1, 2022
-
Mayo Clinic, Orbita to Speak on Successful Utilization of Intelligent Virtual Assistants at HCIC
-
Vaxess Announces $27M in Series B Funding
Vaxess Technologies, Inc., a life sciences company developing a shelf-stable, sustained-release vaccine patch, today announced the closing of its Series B funding.
Nov 1, 2022
-
Creative Enzymes Launches Raw Materials for Manufacturing Diagnostic Kits
-
Creative Enzymes Expands Its Probiotic Portfolio
-
BOC Sciences: Peptides Open New Path toward Osteoporosis Treatment
BOC Sciences declares that some of its peptide products have been proven applicable for osteoporosis treatment, which is a significant contribution to the therapeutic areas.
Nov 1, 2022
-
BOC Sciences Makes Easy Access to Polymerization Tech
Owing to the continuously upgraded synthesis technologies and analytical abilities, BOC Sciences has performed well in the polymer industry, serving the community with a comprehensive product portfolio and valuable technical support.
Nov 1, 2022
-
Rising Prevalence of Isotope Labeling Carbohydrates Drives Innovations at BOC Sciences
BOC Sciences provides global customers with a range of high-quality stable isotope labeling compounds for biomedical research. It recently announced the availability of labeled carbohydrates, arousing an enthusiastic response from the market.
Nov 1, 2022
-
BOC Sciences: ADC Analysis and Characterization Support Development, Registration, and Release
BOC Sciences announces support for antibody-drug conjugate (ADC) development, registration, and release by providing comprehensive analysis and characterization technologies.
Nov 1, 2022
-
Metatranscriptome Analysis Service Is Now Available at CD Genomics
-
Meet CD Genomics at the SITC 37th Annual Meeting